1996
DOI: 10.1016/0027-5107(96)00031-0
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring of occupational exposure to cytostatic anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
72
0
1

Year Published

1998
1998
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 111 publications
(77 citation statements)
references
References 39 publications
4
72
0
1
Order By: Relevance
“…Sessink 8) and Sorsa 48) estimated the carcinogenic risk by CP absorption. Sessink 8) presumed that urinary excretion of unchanged CP was 1 5% and 180 ng of CP was continuously excreted in urine for 200 days ×40 years, and estimated that the occupational risk of developing cancer was 120 600 per million by extrapolation of incidences of tumors in rats, and proposed regular monitoring of urinary CP excretion.…”
Section: Discussionmentioning
confidence: 99%
“…Sessink 8) and Sorsa 48) estimated the carcinogenic risk by CP absorption. Sessink 8) presumed that urinary excretion of unchanged CP was 1 5% and 180 ng of CP was continuously excreted in urine for 200 days ×40 years, and estimated that the occupational risk of developing cancer was 120 600 per million by extrapolation of incidences of tumors in rats, and proposed regular monitoring of urinary CP excretion.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have evidenced a reduced risk when effective protective measures were adopted 10,11) , so in the last few years the interest of occupational medicine in preventing workers' health risks related to antiblastic drugs exposure has been increasing and worldwide attempts have been made to prevent exposure [20][21][22][23] . In particular, recent attention has also focused on nursing staff handling antiblastic drugs that have to be administered to patients, and many European Directives (and related National Legislative Decrees and Guidelines) have been issued, aiming to protect nursing personnel potentially exposed to high amounts of various antiblastic drugs on a daily basis [24][25][26][27] .…”
Section: Journal Of Occupational Healthmentioning
confidence: 99%
“…1 It has also been associated with mutagenic, teratogenic, and reproductive effects. [2][3][4][5][6][7][8][9][10] Pharmacists and pharmacy technicians handle this and other chemotherapy drugs in their most concentrated form over prolonged periods of time. The risk associated with this chronic, low-grade exposure has not been fully established.…”
Section: Introductionmentioning
confidence: 99%